MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/liv.70575

Медицинская библиотека · Liver international : official journal of the International Association for the Study of the Liver · 2026

Liver, Cardiovascular and Infectious Outcomes in Alcohol-Associated Liver Disease With Cardiometabolic Risk Factors.

Danpanichkul Pojsakorn, Duangsonk Kwanjit, Pang Yanfang, Rakwong Krittameth, Jit-Are-Roon Peerapun, Wattanachayakul Phuuwadith, Srikulmontri Thitiphan, Nah Benjamin, Chen Vincent L, Kim Donghee, Mantzoros Christos S, Noureddin Mazen, Wijarnpreecha Karn

СтатьяМногоцентровое исследованиеПеревод пока не подготовлен

Аннотация

BACKGROUND AND AIMS: Cardiometabolic risk factors (CMRF) are common in alcohol-associated liver disease (ALD), but their impact on clinical outcomes is unclear. We evaluated whether CMRF identifies a higher-risk phenotype among adults with ALD.

METHODS

We performed a multicenter retrospective cohort study within the TriNetX research network, including adults with ALD (ICD-10 K70) from 2010 to 2019. CMRFs were defined by overweight/obesity, dysglycemia, hypertension or dyslipidemia using the steatotic liver disease framework. Individuals with other liver diseases, cancer, prior liver transplantation or pregnancy were excluded. After 1:1 propensity score matching (PSM) on demographics, comorbidities, laboratory indices and medications, we compared ALD with versus without CMRF using Cox models, overall and stratified by cirrhosis.

RESULTS

After matching, 2942 adults with ALD were included (ALD with CMRF, n = 1471; without CMRF, n = 1471). Five-year all-cause mortality was similar between groups (Hazard Ratio [HR]: 1.01, 95% CI 0.83-1.23). In contrast, ALD patients with CMRF had higher risks of alcohol-associated hepatitis (HR 2.12, 95% CI 1.62-2.79) and a numerically higher risk of major adverse liver outcomes (HR 1.14, 95% CI 0.98-1.32). Cardiovascular complications were markedly increased, including major adverse cardiovascular events (HR 3.07, 95% CI 2.14-4.39), arrhythmia (12.4% vs. 4.8%, HR 2.24, 95% CI 1.70-2.94) and heart failure (HR 3.70, 95% CI 2.11-6.47). Infectious events were also more frequent among CMRF patients, including sepsis, urinary tract infection and pneumonia. Associations were generally stronger among patients with cirrhosis.

CONCLUSION

Among individuals with ALD, CMRF does not increase short- to intermediate-term mortality but identifies a phenotype with substantially higher liver, cardiovascular and infectious morbidity. Systematic detection and intensive management of CMRF should be integrated into ALD care pathways.

Для цитирования: Danpanichkul Pojsakorn, Duangsonk Kwanjit, Pang Yanfang, Rakwong Krittameth, Jit-Are-Roon Peerapun, Wattanachayakul Phuuwadith, Srikulmontri Thitiphan, Nah Benjamin, Chen Vincent L, Kim Donghee, Mantzoros Christos S, Noureddin Mazen, Wijarnpreecha Karn. Liver, Cardiovascular and Infectious Outcomes in Alcohol-Associated Liver Disease With Cardiometabolic Risk Factors.. Liver international : official journal of the International Association for the Study of the Liver. 2026. DOI: 10.1111/liv.70575.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.